A case shows favorable outcome from multimodal treatment in prostate cancer with brain metastasis, suggesting potential for better management.
Brain metastases from prostate cancer with elevated CEA and CA19-9 are rare. Although these markers often indicate a poor prognosis, this patient achieved a favorable outcome with multimodal treatment. https://thejns.org/doi/10.3171/CASE25735.
No takes yet. Share an insight, caveat, or question.
Sumiyoshi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: